Cytostatic drug therapy in disseminated colorectal cancer.

Abstract

5-FU is the best available single drug in advanced colorectal disease. After systemic administration approximately 15% of the patients achieve a short-lived objective remission. Survival is not prolonged by therapy. Several chemotherapy combinations have in preliminary phase II studies given higher response rates (30-50%), but when evaluated in controlled… (More)

Topics

  • Presentations referencing similar topics